Stockholders' Equity | (3) Stockholders' Equity Dividends On April 12, 2022, our board of directors declared a quarterly dividend of $0.31 per share of common stock to be paid in cash on May 25, 2022 to shareholders of record at the close of business on April 27, 2022. Since 2011, we have paid quarterly cash dividends, and in 2020, we paid a special cash dividend late in the year. Our board of directors currently intends to continue paying quarterly cash dividends, provided that any future determination as to payment of dividends will depend on the financial condition and results of operations of the company and such other factors as are deemed relevant by the board of directors. The following table presents the cash dividends either paid previously or declared by our board of directors for future payment on a per share basis: 2022 2021 First quarter $ 0.31 $ 0.28 Second quarter $ 0.31 $ 0.28 Third quarter $ 0.28 Fourth quarter $ 0.28 Total $ 0.62 $ 1.12 Stock Options The following tables summarize the details of options granted under our stock option plans that were outstanding as of March 31, 2022, and the assumptions used to value these grants. All such grants were effective at the close of business on the date of grant. Options Option Exercise Closing Stock Price on Date March 31, 2022 Date of Grant Options Options January 3, 2022 713,438 $ 62.00 $ 61.980 701,829 53,355 January 4, 2021 741,510 $ 48.00 $ 47.650 691,096 26,643 January 2, 2020 902,263 $ 38.00 $ 37.230 796,263 272,843 January 2, 2019 1,316,924 $ 26.00 $ 25.705 958,946 421,462 January 2, 2018 1,087,936 $ 27.50 $ 27.270 712,852 435,272 January 3, 2017 1,529,578 $ 23.50 $ 23.475 706,446 542,046 April 19, 2016 1,690,880 $ 23.00 $ 22.870 520,571 330,717 April 21, 2015 1,786,440 $ 21.00 $ 20.630 394,072 232,732 April 22, 2014 1,910,000 $ 28.00 $ 25.265 182,839 107,855 April 16, 2013 410,000 $ 27.00 $ 24.625 5,672 5,672 Total 12,088,969 5,670,586 2,428,597 Date of Grant Risk-free Expected Life of Expected Expected Estimated Fair January 3, 2022 1.3 % 5.00 1.7 % 28.52 % $ 13.68 January 4, 2021 0.4 % 5.00 2.0 % 29.17 % $ 9.57 January 2, 2020 1.7 % 5.00 2.4 % 25.70 % $ 6.81 January 2, 2019 2.5 % 5.00 2.9 % 23.96 % $ 4.40 January 2, 2018 2.2 % 5.00 2.3 % 23.45 % $ 5.02 January 3, 2017 1.9 % 5.00 2.6 % 24.49 % $ 4.20 April 19, 2016 1.3 % 5.00 2.6 % 26.34 % $ 4.09 April 21, 2015 1.3 % 5.00 2.7 % 26.84 % $ 3.68 April 22, 2014 1.8 % 5.00 2.0 % 28.55 % $ 4.79 April 16, 2013 0.7 % 5.00 1.6 % 37.42 % $ 6.33 All of the options in the tables above vest and become exercisable over a period of up to eight years. Generally, each option will terminate approximately ten years after the grant date. The fair value of each share-based option is estimated on the date of grant using a Black-Scholes valuation method that uses the assumptions listed above. The risk-free interest rate is based on the U.S. Treasury rate over the expected life of the option at the time of grant. The expected life is the average length of time over which we expect the employee groups will exercise their options, which is based on historical experience with similar grants. The dividend yield is estimated over the expected life of the option based on our current dividend payout, historical dividends paid, and expected future cash dividends. Expected stock volatilities are based on the movement of our stock price over the most recent historical period equivalent to the expected life of the option. Compensation expense equal to the grant date fair value is recognized for all of these awards over the vesting period. The stock-based compensation expense for the three-month periods ended March 31, 2022 and 2021 was $1.5 and $1.5, respectively. Unrecognized stock-based compensation expense related to outstanding unvested stock options as of March 31, 2022 was $18.5 and is expected to be recognized over a weighted average period of 4.56 years. Any future changes in estimated forfeitures will impact this amount. Earnings Per Share The following tables present a reconciliation of the denominators used in the computation of basic and diluted earnings per share and a summary of the options to purchase shares of common stock which were excluded from the diluted earnings per share calculation because they were anti-dilutive: Three-month Period Reconciliation 2022 2021 Basic weighted average shares outstanding 575,559,161 574,336,112 Weighted shares assumed upon exercise of stock options 2,059,645 2,210,857 Diluted weighted average shares outstanding 577,618,806 576,546,969 Three-month Period Summary of Anti-dilutive Options Excluded 2022 2021 Options to purchase shares of common stock 930,401 711,977 Weighted average exercise prices of options $ 58.40 48.00 Any dilutive impact summarized above related to periods when the average market price of our stock exceeded the exercise price of the potentially dilutive stock options then outstanding. Translation Adjustment Upon Merger of Foreign Subsidiary For the three months ended March 31, 2022, we recognized $0.9 of historical cumulative translation to retained earnings upon the merger of a foreign subsidiary. |